Drug intelligence / Profile preview

Lemonaid Health Sildenafil

Development stage: Unknown
Lead developer: Pfizer
Modality: Small Molecules
Administration: Oral

Overview

Lemonaid Health Sildenafil is a branded generic version of sildenafil citrate, an oral phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction. It is provided by Lemonaid Health, a telehealth platform. The drug works by inhibiting the PDE5 enzyme, which prevents the degradation of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum. This leads to smooth muscle relaxation and increased blood flow to the penis during sexual stimulation. In clinical trial contexts, it is often used as a reference or comparator for novel sildenafil formulations like liquid or metered-dose sprays.

Brand names: Lemonaid Health Sildenafil
Other names: Lemonaid Health-branded sildenafil tablets

Targets

PDE5 (Phosphodiesterase 5A)

Beyond the preview

Go deeper on Lemonaid Health Sildenafil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lemonaid Health Sildenafil.

Explore the full profile